Market Research Logo

Conference Documentation: Controlled Release

Conference Documentation: Controlled Release

As controlled release drug delivery systems continue to play an important role among the emerging areas of research in the treatment of diseases, this event will focus on specific topics looking at advances made in the field and how to overcome the challenges involved when developing controlled release formulations.

Returning for its twelfth year and following on from the major success of previous events, SMi are proud to present the 12th annual Controlled Release Conference, 20th - 21st April 2015, London, UK.
Through a series of interactive presentations and panel discussions, the goal of this major networking event is to spotlight principles and illustrative examples facilitating access to the findings of industry innovators on current activities and trends. Ultimately serving as a valuable resource for capturing the ‘big picture’ of the latest research and developments, this is a must attend event!

Key topics include:

Ocular treatment - beating the challenge of systemic long term delivery in the eye
Delivery of therapeutic antibodies… overcoming the technical challenges to add value to the patient whilst ensuring efficacy and stability of the drug
Use of solid dispersions to increase the solubility of drugs in terms of controlled release and assimilation
Alternative Pathways for controlled release delivery
Controlled release in animal health, challenges for testing

And much more!


Day 1
8:30
Registration & Coffee
9:00
Chairman's Opening Remarks
Howard Stevens, Emeritus Professor, University Of Strathclyde
9:10
Sustained ocular drug release.... beating the challenges of long term delivery of biologics to the eye
Ian Catchpole, Senior Investigator Senior Investigator BioPharm Innovation, GlaxoSmithKline
9:50
Overcoming the impact of patient factors in oral drug delivery
Howard Stevens, Emeritus Professor, University Of Strathclyde
10:30
Morning Coffee
11:00
Circadian drug delivery: Chronocort® a case study
Daniel Margetson, Director CMC, Diurnal
11:40
The selection and development of oral drug delivery technologies: GSK’s experiences and perspectives
Mark Wilson, Director, Collaboration Management, Europe, Platform Technology and Science, GlaxoSmithKline
12:20
Networking Lunch
13:20
Oral delivery of proteins and peptides: future prospects
Stephen Timothy Buckley, Senior Research Scientist, ADME, Novo Nordisk A/S
14:00
Opportunities and challenges in the development of controlled release systems for therapeutic antibodies
Daniel Schweizer, Functional Lead, Technical Research & Development, Biologics Process R&D, Pharmaceutical Development, Novartis Pharmaceuticals
14:40
Afternoon Tea
15:10
How can drug half-life extension improve patient care … the science behind albumin engineering to improve drug efficacy and tolerability
Darrell Sleep, Director, Biopharma R&D, Novozymes Biopharma UK Ltd
15:50
Use of solid dispersions to increase the solubility of drugs in terms of controlled release and assimilation
Teofilo Vasconcelos, Senior Formulation Scientist Pharmaceutical Development, Bial
16:30
Capturing prior knowledge in formulation platforms to facilitate and rationalize decision-making. How do modified release formulations fit into a platform applicable to a broader range of APIs?
Morten Allesø, Principal Pharmaceutical Researcher, Biologics and Pharmaceutical Science, H. Lundbeck A/S
17:10
Chairman’s Closing Remarks and Close of Day One
Day 2
8:30
Registration & Coffee
9:00
Chairman's Opening Remarks
Ian Catchpole, Senior Investigator Senior Investigator BioPharm Innovation, GlaxoSmithKline
9:10
Novel drug delivery technologies for biomedical applications
Helder Santos, Head of the Pharmaceutical Nanotechnology and Chemical Microsystems (NAMI) Unit, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy,, University Of Helsinki
9:50
Oral Peptide Delivery Landscape
Andy Lewis, Director Novel Formulation Technologies, Ipsen
10:30
Morning Coffee
11:00
Oral inhalation – it’s not just for pulmonary disease anymore
Kelly S Kraft, Director of Pharmaceutical Research, Mannkind Corporation
11:40
Investigation of parenteral depots: composition, dynamic structure and in vitro release
Michael Keller, Senior Fellow, Technical R&D, Novartis Pharma AG
12:20
Networking Lunch
13:20
Dissolution behavior and test methods of orally inhaled products
Sabine May, Scientific Assistant, Boehringer Ingelheim Pharma GmbH & Co. KG
14:00
A new three-dimensional cell-based intestinal in vitro model to explore intestinal absorption
Bruno Sarmento, Affiliated Researcher /Assistant Professor, INEB – Institute of Biomedical Engineering, University of Porto / Instituto Superior de Ciências da Saúde-Norte
14:40
Afternoon Tea
15:10
Controlled Release in animal health
Martin Folger , Head, Pharmaceutical Development, Boehringer Ingelheim Vetmedica GmbH
15:50
Continuous manufacturing of pharmaceutical cocrystal by using hot melt extrusion
Dennis douroumis, Assistant Professor, Faculty of Engineering and Sciences, , Faculty of Engineering and Sciences, University Of Greenwich
16:30
Chairman’s Closing Remarks and Close of Day Two

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report